Abstract
Purpose
Patients treated with cytotoxic chemotherapy are at risk of neutropenia, neutropenic fever and neutropenic sepsis. We hypothesised that pre-existing neutrophil function dysfunction may increase susceptibility to neutropenic fever in paediatric patients receiving cytotoxic chemotherapy.
Methods
Prospective cohort study recruited patients at Alder Hey Children’s NHS Foundation Trust, United Kingdom. We measured neutrophil phagocytic function using a validated flow cytometric whole blood phagocytosis assay in paediatric patients (n = 16) with oncological disease before and after chemotherapy in a prospective cohort study. We recruited healthy children as a control comparator (n = 10).
Results
We found significantly decreased phagocytic function in oncology patients compared to healthy participants. In five patients who developed neutropenic fever, we observed increased pre-dose neutrophil respiratory burst.
Conclusion
With further validation, measurement of neutrophil function could potentially be used to personalise appropriate prophylactic antimicrobial administration for patients receiving cytotoxic chemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 2121-2125 |
| Number of pages | 5 |
| Journal | Clinical and Translational Oncology |
| Volume | 22 |
| Issue number | 11 |
| Early online date | 14 May 2020 |
| DOIs | |
| Publication status | Published - 1 Nov 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarker
- Cytotoxic chemotherapy
- Flow cytometry
- Neutrophils
- Paediatric cancer
- Phagocytosis
Fingerprint
Dive into the research topics of 'Neutrophil function is impaired in paediatric patients with malignancy and may be a useful clinical marker'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver